Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aarti Bhatia
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
172 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Epic Care-Dublin
Dublin, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Va Palo Alto Health Care System
Palo Alto, California, United States
- Smilow Cancer Hospital-Derby Care Center
Derby, Connecticut, United States
- Smilow Cancer Hospital Care Center-Fairfield
Fairfield, Connecticut, United States
- Smilow Cancer Hospital Care Center at Glastonbury
Glastonbury, Connecticut, United States
- Smilow Cancer Hospital Care Center at Greenwich
Greenwich, Connecticut, United States
- Smilow Cancer Hospital Care Center - Guilford
Guilford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Yale-New Haven Hospital North Haven Medical Center
North Haven, Connecticut, United States
- Smilow Cancer Hospital-Orange Care Center
Orange, Connecticut, United States
- Smilow Cancer Hospital Care Center at Long Ridge
Stamford, Connecticut, United States
- Smilow Cancer Hospital-Torrington Care Center
Torrington, Connecticut, United States
- Smilow Cancer Hospital Care Center-Trumbull
Trumbull, Connecticut, United States
- Smilow Cancer Hospital-Waterbury Care Center
Waterbury, Connecticut, United States
- Smilow Cancer Hospital Care Center - Waterford
Waterford, Connecticut, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Medical Oncology Hematology Consultants Pa
Newark, Delaware, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Um Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Deerfield Beach
Deerfield Beach, Florida, United States
- Broward Health Medical Center
Fort Lauderdale, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Kendall
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Plantation
Plantation, Florida, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, United States
- Queen'S Cancer Cenrer - Pob I
Honolulu, Hawaii, United States
- Queen'S Cancer Center - Kuakini
Honolulu, Hawaii, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Hawaii Cancer Care - Westridge
‘Aiea, Hawaii, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Mar 2023
- Primary completion
- 15 Dec 2027
- Completion
- 15 Dec 2027
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 430
- Registry id
- NCT05063552
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.